PMC:7534795 / 115708-115856
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T650","span":{"begin":5,"end":13},"obj":"Disease"},{"id":"T651","span":{"begin":14,"end":23},"obj":"Disease"}],"attributes":[{"id":"A650","pred":"mondo_id","subj":"T650","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A651","pred":"mondo_id","subj":"T651","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"vere COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007). The triglyceride-lowering effect of n-3 PUFA supplementation has"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T165","span":{"begin":145,"end":148},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"vere COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007). The triglyceride-lowering effect of n-3 PUFA supplementation has"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T67036","span":{"begin":88,"end":100},"obj":"Chemical"},{"id":"T15031","span":{"begin":124,"end":128},"obj":"Chemical"}],"attributes":[{"id":"A84238","pred":"chebi_id","subj":"T67036","obj":"http://purl.obolibrary.org/obo/CHEBI_17855"},{"id":"A23964","pred":"chebi_id","subj":"T15031","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A10339","pred":"chebi_id","subj":"T15031","obj":"http://purl.obolibrary.org/obo/CHEBI_76567"}],"text":"vere COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007). The triglyceride-lowering effect of n-3 PUFA supplementation has"}
2_test
{"project":"2_test","denotations":[{"id":"33031856-22819432-84039158","span":{"begin":53,"end":57},"obj":"22819432"},{"id":"33031856-17825687-84039159","span":{"begin":77,"end":81},"obj":"17825687"}],"text":"vere COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007). The triglyceride-lowering effect of n-3 PUFA supplementation has"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"3303","span":{"begin":124,"end":128},"obj":"Gene"},{"id":"3313","span":{"begin":88,"end":100},"obj":"Chemical"},{"id":"3325","span":{"begin":5,"end":13},"obj":"Disease"},{"id":"3326","span":{"begin":14,"end":23},"obj":"Disease"}],"attributes":[{"id":"A3303","pred":"tao:has_database_id","subj":"3303","obj":"Gene:9933"},{"id":"A3313","pred":"tao:has_database_id","subj":"3313","obj":"MESH:D014280"},{"id":"A3325","pred":"tao:has_database_id","subj":"3325","obj":"MESH:C000657245"},{"id":"A3326","pred":"tao:has_database_id","subj":"3326","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"vere COVID-19 infection outcomes (Ballantyne et al., 2012; Davidson, et al., 2007). The triglyceride-lowering effect of n-3 PUFA supplementation has"}